RENAL CELL CARCINOMA (RCC)
Clinical trials for RENAL CELL CARCINOMA (RCC) explained in plain language.
Never miss a new study
Get alerted when new RENAL CELL CARCINOMA (RCC) trials appear
Sign up with your email to follow new studies for RENAL CELL CARCINOMA (RCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Drug combo aims to shield kidneys after cancer surgery
Disease control TerminatedThis study tested whether two medications, finerenone and empagliflozin, taken alone or together, could slow kidney function loss in people at high risk for chronic kidney disease after having a kidney removed due to cancer. Ten participants took the drugs daily for one year and …
Matched conditions: RENAL CELL CARCINOMA (RCC)
Phase: PHASE2 • Sponsor: Jinling Hospital, China • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Kidney cancer drug combo trial halted early – what we know
Disease control TerminatedThis study tested a combination of two drugs (toripalimab and lenvatinib) given before and after kidney cancer surgery in 17 people with different stages of kidney cancer. The goal was to see if the treatment could shrink or eliminate the tumor before surgery and help control the…
Matched conditions: RENAL CELL CARCINOMA (RCC)
Phase: PHASE2 • Sponsor: Jinling Hospital, China • Aim: Disease control
Last updated May 13, 2026 16:03 UTC